Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06385548
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-04-11
Brief Title:
Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients Protocol VHIO21001 - LiDer
Sponsor:
Organization:
Vall dHebron Institute of Oncology